Peter S Kim, Alise S Reicin. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cardiovascular Diseases/chemically inducedCardiovascular Diseases/mortalityCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/historyDrug Approval/historyDrug Industry/historyHistory, 20th CenturyHistory, 21st CenturyHumansLactones/adverse effectsLactones/historyRandomized Controlled Trials as Topic/historySulfones/adverse effectsSulfones/historyUnited StatesUnited States Food and Drug Administration
Substances: See more » Cyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2004 PMID: 15625342 DOI: 10.1056/NEJM200412303512719
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245